 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
Acceleron Exploring New Biomarker Leads to Personalize Treatment for Breast, Head and Neck Cancers
October 17, 2012
Acceleron Exploring New Biomarker Leads to Personalize Treatment for Breast, Head and Neck Cancers
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Sequencing of Cell-Free DNA Holds Promise for Monitoring Cancer During Treatment, Study Suggests
March 20, 2013 / Clinical Sequencing News - Nuclea, Wilex Partner to Offer Breast Cancer Testing Service
March 20, 2013 / GenomeWeb Daily News - Searching Cancer Stem-like Cells, Researchers ID miRNA Linked to Breast Cancer Brain Metastasis
February 7, 2013 / Gene Silencing News - 23andMe, Genentech Expand Study Targeting Avastin
January 29, 2013 / GenomeWeb Daily News - China Approves Veridex's CellSearch Test for Metastatic Breast Cancer
December 13, 2012 / GenomeWeb Daily News